490 related articles for article (PubMed ID: 2704827)
1. Gd-DTPA as a contrast agent in CT.
Bloem JL; Wondergem J
Radiology; 1989 May; 171(2):578-9. PubMed ID: 2704827
[TBL] [Abstract][Full Text] [Related]
2. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media].
De Cobelli F; Vanzulli A; Colombo E; Bonato C; Sironi S; Del Maschio A
Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756
[TBL] [Abstract][Full Text] [Related]
3. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
[TBL] [Abstract][Full Text] [Related]
4. Dynamic Gd-DTPA-enhanced MR imaging of the kidney: experimental results.
Choyke PL; Frank JA; Girton ME; Inscoe SW; Carvlin MJ; Black JL; Austin HA; Dwyer AJ
Radiology; 1989 Mar; 170(3 Pt 1):713-20. PubMed ID: 2916025
[TBL] [Abstract][Full Text] [Related]
5. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver.
Pavone P; Patrizio G; Buoni C; Tettamanti E; Passariello R; Musu C; Tirone P; Felder E
Radiology; 1990 Jul; 176(1):61-4. PubMed ID: 2353112
[TBL] [Abstract][Full Text] [Related]
7. Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions.
Russell EJ; Schaible TF; Dillon W; Drayer B; LiPuma J; Mancuso A; Maravilla K; Goldstein HA
AJR Am J Roentgenol; 1989 Apr; 152(4):813-23. PubMed ID: 2646872
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
9. Use of Gd-DTPA and fast gradient-echo and spin-echo MR imaging to demonstrate renal function in the rabbit.
Carvlin MJ; Arger PH; Kundel HL; Axel L; Dougherty L; Kassab EA; Moore B
Radiology; 1989 Mar; 170(3 Pt 1):705-11. PubMed ID: 2916024
[TBL] [Abstract][Full Text] [Related]
10. Liposomal Gd-DTPA: preparation and characterization of relaxivity.
Tilcock C; Unger E; Cullis P; MacDougall P
Radiology; 1989 Apr; 171(1):77-80. PubMed ID: 2928549
[TBL] [Abstract][Full Text] [Related]
11. MR contrast enhancement of intracranial lesions with Gd-DTPA.
Hesselink JR; Press GA
Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
[TBL] [Abstract][Full Text] [Related]
12. [Magnetic resonance tomographic studies of paragangliomas of the glomus caroticum and glomus jugulare using Gd-DTPA].
Vogl T; Bauer M; Schedel H; Brüning R; Mees K; Lissner J
Rofo; 1988 Jan; 148(1):38-46. PubMed ID: 2829304
[TBL] [Abstract][Full Text] [Related]
13. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors.
Haughton VM; Rimm AA; Czervionke LF; Breger RK; Fisher ME; Papke RA; Hendrix LE; Strother CM; Turski PA; Williams AL
Radiology; 1988 Mar; 166(3):829-33. PubMed ID: 3340779
[TBL] [Abstract][Full Text] [Related]
15. [MRI of the nasopharynx with Gd-DTPA: its value and differential diagnostic criteria].
Vogl T; Dresel S; Schedel H; Markl A; Grevers G; Stelzer S; Lissner J
Rofo; 1989 May; 150(5):516-22. PubMed ID: 2541475
[TBL] [Abstract][Full Text] [Related]
16. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.
Hamm B; Staks T; Mühler A; Bollow M; Taupitz M; Frenzel T; Wolf KJ; Weinmann HJ; Lange L
Radiology; 1995 Jun; 195(3):785-92. PubMed ID: 7754011
[TBL] [Abstract][Full Text] [Related]
17. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R
Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
[TBL] [Abstract][Full Text] [Related]
18. Tumors of the nasopharynx and adjacent areas: MR imaging with Gd-DTPA.
Vogl T; Dresel S; Bilaniuk LT; Grevers G; Kang K; Lissner J
AJR Am J Roentgenol; 1990 Mar; 154(3):585-92. PubMed ID: 2154915
[TBL] [Abstract][Full Text] [Related]
19. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences].
Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R
Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777
[TBL] [Abstract][Full Text] [Related]
20. [Magnetic resonance tomographic screening studies of the bone marrow with gradient-echo sequences. II. Gadolinium-DTPA-supported studies of plasmocytoma patients].
Hosten N; Schörner W; Neumann K; Sander B; Oertel J; Kirsch A; Schubeus P; Cordes M; Felix R; Huhn D
Rofo; 1992 Jul; 157(1):53-8. PubMed ID: 1638006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]